SLC17A8 Gene Deafness Autosomal Dominant Type 25 Genetic Test sale cost 4400 AED
COL4A3 Gene Alport syndrome autosomal recessive Genetic Test sale cost 4400 AED COL4A3 Gene Alport syndrome autosomal recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
GJB2 Gene Deafness Autosomal Recessive Type 1A Genetic Test sale cost 4400 AED GJB2 Gene Deafness Autosomal Recessive Type 1A Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SLC17A8 Gene Deafness Autosomal Dominant Type 25 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC17A8 gene is implicated in a form of hearing loss known as Deafness Autosomal Dominant Type 25 (DFNA25). This condition is characterized by a variation in the SLC17A8 gene, which plays a critical role in the function of the inner ear, affecting the ability to hear. Genetic testing for mutations in the SLC17A8 gene is crucial for diagnosing this specific type of hereditary hearing loss, enabling individuals and families to understand their condition better and make informed decisions regarding their health and management options.

At DNA Labs UAE, a specialized genetic test is available to identify mutations in the SLC17A8 gene associated with Deafness Autosomal Dominant Type 25. The test is a comprehensive analysis designed to detect the specific genetic alterations that lead to this condition, providing a definitive diagnosis for affected individuals or those at risk.

The cost of the SLC17A8 gene deafness autosomal dominant type 25 genetic test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the genetic analysis, including the collection of a DNA sample, typically through a blood draw or cheek swab, the laboratory processing, and the expert interpretation of the results. Following the test, individuals receive a detailed report that explains the findings and their implications for hearing health, with recommendations for follow-up care or interventions as needed. This genetic test is a valuable tool for those with a family history of hearing loss or early signs of hearing impairment, offering insights that can lead to early intervention and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC17A8 Gene Deafness autosomal dominant type 25 Genetic Test

At DNA Labs UAE, we offer the SLC17A8 Gene Deafness autosomal dominant type 25 Genetic Test at a cost of AED 4400.0.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

If you are considering the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS4.

Test Details

The SLC17A8 gene is associated with a type of autosomal dominant deafness known as deafness type 25. This means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition. Our NGS (Next-Generation Sequencing) genetic testing uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of deafness type 25, our NGS genetic testing can identify mutations in the SLC17A8 gene that are responsible for the condition.

To perform the NGS genetic test for SLC17A8 gene deafness type 25, we will need a DNA sample from the individual undergoing testing. This can be obtained through a blood sample or a cheek swab. The DNA sample will then be sequenced using NGS technology to identify any mutations or variations in the SLC17A8 gene. The results of the NGS genetic test can help confirm a diagnosis of deafness type 25 and provide information about the specific mutation in the SLC17A8 gene.

This information can be valuable for genetic counseling, understanding the inheritance pattern, and potentially guiding treatment options or interventions for individuals affected by this condition.

Test Name SLC17A8 Gene Deafness autosomal dominant type 25 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS4
Test Details

The SLC17A8 gene is associated with a type of autosomal dominant deafness known as deafness type 25. Autosomal dominant means that a person only needs to inherit one copy of the mutated gene from either parent to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of deafness type 25, NGS genetic testing can be used to identify mutations in the SLC17A8 gene that are responsible for the condition.

The NGS genetic test for SLC17A8 gene deafness type 25 involves obtaining a DNA sample from the individual undergoing testing, usually through a blood sample or a cheek swab. The DNA sample is then sequenced using NGS technology to identify any mutations or variations in the SLC17A8 gene.

The results of the NGS genetic test can help confirm a diagnosis of deafness type 25 and provide information about the specific mutation in the SLC17A8 gene. This information can be useful for genetic counseling, understanding the inheritance pattern, and potentially guiding treatment options or interventions for individuals affected by this condition.

SKU: TEST-2681 Category:

Related products